Expression of Rgs2, an inhibitor of cell proliferation and mediator of cell differentiation (244), was shown to be highly upregulated in MDSCs from tumor-bearing mice, and knockout of Rgs2 led to decreased CCL2 expression and reduced tumor growth due to decreased vascularization in vivo. The gene discussed is RGS2; the disease is neoplasm.